ADL-5747
| Names | |
|---|---|
| IUPAC name
N,N-diethyl-3-hydroxy-4-spiro[chromene-2,4'-piperidine]-4-ylbenzamide | |
| Identifiers | |
| |
3D model (JSmol) |
|
| ChEMBL | |
| ChemSpider | |
PubChem CID |
|
| UNII | |
| |
| |
| Properties | |
| C24H28N2O3 | |
| Molar mass | 392.499 g·mol−1 |
| Related compounds | |
Related compounds |
ADL-5859 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references | |
ADL-5747 was a novel opioid analgesic drug, however its development was halted because it did not pass phase II trials.